Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia.

Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Abstract Text:

Andrea ,Matthias Niedermeier,Annette ,William G Wierda,Michael J Keating,Jan A Burger,Andrea ,Matthias Niedermeier,Annette ,William G Wierda,Michael J Keating,Jan A Burger,

CXCL13 is a homeostatic chemokine for lymphocyte homing and positioning within follicles of secondary lymphoid tissues, acting through its cognate receptor, CXCR5. Moreover, the CXCR5-CXCL13 axis plays a unique role in trafficking and homing of B1 cells. Here, we report that chronic lymphocytic leukemia (CLL) B cells express high levels of functional CXCR5. CXCR5 expression levels were similar on CLL B cells and normal CD5+ B cells, and higher compared with normal CD5- B cells, follicular B-helper T cells (T(FH) cells), or neoplastic B cells from other B-cell neoplasias. Stimulation of CLL cells with CXCL13 induces actin polymerization, CXCR5 endocytosis, chemotaxis, and prolonged activation of p44/42 mitogen-activated protein kinases. Anti-CXCR5 antibodies, pertussis toxin, and wortmannin inhibited chemotaxis to CXCL13, demonstrating the importance of Gi proteins and PI3 kinases for CXCR5 signaling. Moreover, CLL patients had significantly higher CXCL13 serum levels than volunteers, and CXCL13 levels correlated with beta2 microglobulin. We detected CXCL13 mRNA expression by nurselike cells, and high levels of CXCL13 protein in supernatants of CLL nurselike cell cultures. By immunohistochemistry, we detected CXCL13+ expression by CD68+ macrophages in situ within CLL lymph nodes. These data suggest that CXCR5 plays a role in CLL cell positioning and cognate interactions between CLL and CXCL13-secreting CD68+ accessory cells in lymphoid tissues.

Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Publishing Authors By Initials

A ,M Niedermeier,A ,WG Wierda,MJ Keating,JA Burger,A ,M Niedermeier,A ,WG Wierda,MJ Keating,JA Burger,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Blood

VOLUME: 110

Page Numbers: 3316-25

Journal Abbreviation: Blood

ISSN: 0006-4971

DAY: 25

MONTH: 07

YEAR: 2007

Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7603509

Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia.

AFFILIATION: Department of Medicine, Division of Hematology/Oncology, Freiburg University Hospital, Freiburg, Germany.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Blood

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia Related Publications

• A framework and methods for incorporating gender-related issues in wildlife risk assessment: gender-related differences in metal levels and other contaminants as a case study.
• A model for selecting bioindicators to monitor radionuclide concentrations using Amchitka Island in the Aleutians as a case study.
• Assessment and management of risk to wildlife from cadmium.
• Bladder sparing approach for initial T1G3 bladder cancer: Do multifocality, size of tumor or concomitant carcinoma in situ matter? A long-term analysis of 132 patients.
• Cancer stem cells and individualized therapy.
• Continuous-wave broadly tunable Cr(2+):ZnSe laser.
• Editorial comment on: Long-term tolerability of tolterodine extended release in children 5-11 years of age: results from a 12-month, open-label study.
• Genomic and nongenomic effects of estrogen signaling in human endometrial cells: involvement of the growth factor receptor signaling downstream AKT pathway.
• Interaction study of the combined use of paroxetine and fosamprenavir-ritonavir in healthy subjects.
• Mixed effects modeling of weight change associated with placebo and pregabalin administration.
• Molecular analysis of xenograft models of human cancer cachexia--possibilities for therapeutic intervention.
• Monoclonal antibodies to guinea pig interferon-gamma: Tools for cytokine detection and neutralization.
• Not Available
• Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia.
• Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patients.
• Product update.
• Protective sustainability of ecosystems using Department of Energy buffer lands as a case study.
• Quantitative thin-layer chromatography of cobalamin complexes.
• Telomerase and its potential for therapeutic intervention.
• Telomerase in cancer diagnosis and therapy: a clinical perspective.
• The assessment of alexithymia in medical settings: implications for understanding and treating health problems.
• The effect on ecological systems of remediation to protect human health.
• Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practice.
• Therapeutic implications of leukemic stem cell pathways.
• Treatment seeking for alcohol and drug use disorders by immigrants to the Netherlands: retrospective, population-based, cohort study.
• [Endothelioma as variety of tubular mesothelioma of the ovary.]
• [Horner's syndrome after fracture of the first rib]
• [New knowledge and experience with the urinary organs in pregnancy.]
• [Not Available.]
• [ON TRANSVERSE PRESENTATION.]